Psychiatry MMC | A peer-reviewed journal providing evidence-based information to practicing clinicians

Sponsor

Free NEI Membership Offer

Receive a free two-month membership term to NEI when you register on Psychiatry (Edgemont)'s website!

Click here for more info

Join our Facebook Group


Elizabeth Klumpp's Facebook Profile

The Use of Placebo-Controlled Clinical Trials for the Approval of Psychiatric Drugs: Part I—Statistics and the Case for the “Greater Good”

March 2009

by David Feifel, MD, PhD

Dr. Feifel is Professor, Department of Psychiatry; Director, Neuropsychiatry and Behavioral Medicine Program; Director, UCSD Adult ADHD Program, University of California, San Diego Medical Center, San Diego, California.

This is protected content.
:
:
Content Protected by SmartLogix

Popularity: unranked [?]

Share and Enjoy:
  • HealthRanker
  • Google Bookmarks
  • LinkedIn
  • Facebook
  • Digg
  • Yahoo! Buzz
  • StumbleUpon
  • del.icio.us
  • ThisNext

Posted in Research to Practice | No Comments »

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.